Ranked by reported Q2 2026 13F market value
Share of total reported institutional value in VERA held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 5.7M | $246.6M | +13.0% | 8.007% | 0.00% |
| 2 | Avoro Capital Advisors LLC | 5.7M | $245.6M | -2.8% | 7.974% | 2.21% |
| 3 | STATE STREET CORP | 4.1M | $178.0M | +23.3% | 5.780% | 0.00% |
| 4 | Deep Track Capital, LP | 4.0M | $171.6M | -2.6% | 5.572% | 2.50% |
| 5 | DEERFIELD MANAGEMENT COMPANY, L.P. | 3.9M | $168.1M | +5.2% | 5.456% | 1.75% |
| 6 | Kynam Capital Management, LP | 2.9M | $124.0M | -14.9% | 4.026% | 6.85% |
| 7 | MORGAN STANLEY | 2.8M | $120.1M | +659.1% | 3.900% | 0.01% |
| 8 | Sofinnova Investments, Inc. | 2.8M | $119.9M | 0.0% | 3.892% | 6.20% |
| 9 | FMR LLC | 2.8M | $119.0M | +3.6% | 3.865% | 0.01% |
| 10 | VANGUARD CAPITAL MANAGEMENT LLC | 2.8M | $118.2M | +2.7% | 3.839% | 0.00% |
| 11 | Eversept Partners, LP | 2.2M | $94.9M | +1.8% | 3.083% | 4.93% |
| 12 | Logos Global Management LP | 2.2M | $94.4M | — | 3.065% | 4.06% |
| 13 | Integral Health Asset Management, LLC | 1.8M | $75.1M | +9.4% | 2.438% | 2.97% |
| 14 | Bellevue Group AG | 1.7M | $73.4M | 0.0% | 2.383% | 1.54% |
| 15 | GEODE CAPITAL MANAGEMENT, LLC | 1.7M | $72.6M | +7.8% | 2.358% | 0.00% |
| 16 | ALLIANCEBERNSTEIN L.P. | 1.6M | $64.0M | +21.1% | 2.216% | 0.02% |
| 17 | GOLDMAN SACHS GROUP INC | 1.4M | $59.3M | +21.8% | 1.924% | 0.01% |
| 18 | FRONTIER CAPITAL MANAGEMENT CO LLC | 1.3M | $55.6M | +134.9% | 1.805% | 0.52% |
| 19 | Pictet Asset Management Holding SA | 1.2M | $53.6M | +18.8% | 1.740% | 0.05% |
| 20 | DEUTSCHE BANK AG\ | 1.1M | $47.3M | +107.0% | 1.535% | 0.01% |
| 21 | Qube Research & Technologies Ltd | 1.1M | $46.5M | +99.9% | 1.509% | 0.04% |
| 22 | Woodline Partners LP | 1.0M | $43.0M | 0.0% | 1.395% | 0.13% |
| 23 | AMERICAN CENTURY COMPANIES INC | 866K | $37.2M | +18.9% | 1.207% | 0.02% |
| 24 | VANGUARD PORTFOLIO MANAGEMENT LLC | 643K | $27.6M | +16.3% | 0.896% | 0.00% |
| 25 | VOYA INVESTMENT MANAGEMENT LLC | 643K | $27.6M | +121.2% | 0.895% | 0.02% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in VERA — a direct measure of their conviction.
Filings activity in VERA during Q2 2026, grouped by how each filer changed its position.
Institutions that opened a new VERA position in Q2 2026
Institutions that fully closed their VERA position in Q2 2026
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q2 2026 | 220 | 3.5% | 109.10% | +6.74 pp | $3.18B | +15% |
| Q1 2026 | 228 | +6.5% | 102.36% | 3.27 pp | $2.77B | 21% |
| Q4 2025 | 214 | +25% | 105.63% | +3.20 pp | $3.51B | +97% |
| Q3 2025 | 171 | +1.8% | 102.43% | +2.03 pp | $1.78B | +28% |
| Q2 2025 | 168 | 4.0% | 100.40% | +1.14 pp | $1.38B | +1.6% |
| Q1 2025 | 175 | 0.6% | 99.26% | +0.11 pp | $1.36B | 42% |
| Q4 2024 | 176 | +1.7% | 99.15% | +1.29 pp | $2.35B | +11% |
| Q3 2024 | 173 | — | 97.86% | — | $2.12B | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying VERA stock.
Based on Q2 2026 13F filings, institutional ownership of Vera Therapeutics, Inc. stands at 109.1%, held across 220 reporting institutions.
BlackRock, Inc. is the largest reported institutional holder of VERA, with approximately 5,747,760 shares worth $0.25B as of Q2 2026.
No marquee "smart money" managers (Berkshire, Burry, ARK, Tiger Global, Pershing Square, Baupost, etc.) currently appear among the top 25 institutional holders of VERA.
Our composite Smart Money Score for VERA is 41 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
27 institutions opened new positions in VERA during Q2 2026, while 35 fully exited. 134 added to existing positions and 54 trimmed.
VERA institutional ownership rose by 6.74 percentage points quarter-over-quarter, with a net change of -8 holders.
The top 10 institutions account for 50.7% of all reported 13F value in VERA, and the top 25 account for 78.2%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Vera Therapeutics, Inc. (VERA) Institutional Ownership